STOCK TITAN

CARTESIAN GRTH CP II CL A (RENEF) Financials

RENEF
FY2025 annual
Revenue Not reported for FY2025
Net Income -$1.5M -118.4% YoY
EPS (Diluted) Not reported for FY2025
Operating Cash Flow -$774K +5.0% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the RENEF SEC filings page.

This page shows CARTESIAN GRTH CP II CL A (RENEF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RENEF FY2025

The dominant mechanic is a balance-sheet wind-down: capital-return flows shrink assets while operating activity continues consuming cash and equity.

From FY2022 to FY2025, total assets contracted from $240.6M to $38.3M, while investing inflows and financing outflows repeatedly moved in near-offsetting directions; this indicates balance-sheet wind-down rather than operating expansion. Operating cash flow remained negative in every reported year, reaching -$774K in FY2025 despite positive net income in FY2024 and a FY2025 loss; earnings therefore did not translate into operating cash.

The current ratio fell from 3.9x in FY2022 to 0.1x in FY2025. Current liabilities rose from $219K to $5.7M, so short-term claims expanded against a much smaller immediately available asset base.

The company’s negative equity deepened from -$18.0M in FY2022 to -$26.3M in FY2025, alongside reported share buybacks in FY2025. This combination points to capital being redistributed or released as the balance sheet contracted, rather than reinvested to build operating capacity.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

CARTESIAN GRTH CP II CL A does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
1/5

CARTESIAN GRTH CP II CL A passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing
N/A

CARTESIAN GRTH CP II CL A reported a net loss of $1.5M while operations used $774K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$700K
YoY-359.6%
QoQ-122.6%

CARTESIAN GRTH CP II CL A reported -$700K in net income in Q2 2026. This represents a decrease of 359.6% from the same quarter a year earlier. Against the prior quarter it is down 122.6%.

Revenue

Not reported for Q2 2026.

EBITDA

Not reported for Q2 2026.

EPS (Diluted)

Not reported for Q2 2026.

Cash & Balance Sheet

Cash & Debt
$149K
YoY-35.1%
QoQ+41.5%

CARTESIAN GRTH CP II CL A held $149K in cash as of Q2 2026; long-term debt is not reported for that period.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Shares Outstanding

Not reported for Q2 2026.

Margins & Returns

None of these metrics is reported for Q2 2026.

Capital Allocation

None of these metrics is reported for Q2 2026.

RENEF Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RENEF quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
SG&A Expenses$527K+101.1%$242K+708.1%N/AN/A$262K$30KN/AN/A
Operating Income-$527K-101.1%-$242K-24.1%N/A-$203K+6.4%-$262K-32.2%-$195K+12.5%N/A-$217K+0.6%
Net Income-$700K-359.6%$3.1M+452.8%N/A$338K-88.4%-$152K-107.2%$560K-77.9%N/A$2.9M+55.9%

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, EBITDA, Interest Expense, Income Tax, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

RENEF Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RENEF quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$38.6M-55.8%$38.4M-55.3%$38.3M-55.0%$88.6M-51.5%$87.4M-51.4%$86.0M-51.5%$85.0M-51.3%$182.8M-26.5%
Current Assets$236K-34.4%$244K-14.4%$363K-17.2%$115K-54.4%$360K+101.3%$285K-20.2%$439K+33.0%$251K+211.9%
Cash & Equivalents$149K-35.1%$105K+29.6%$163K-31.2%$44K-77.9%$230K+503.3%$81K-32.7%$237K+364.7%$200K+640.4%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0-100.0%$0-100.0%$37.9M-55.2%$88.5M-51.5%$87.0M-51.6%$85.7M-51.6%$84.6M-51.5%$182.5M-26.6%
Total Liabilities$63.0M-42.5%$61.9M-42.1%$64.6M-38.6%$112.0M-44.6%$109.7M-45.0%$106.8M-45.5%$105.3M-45.5%$202.0M-24.2%
Current Liabilities$6.1M+30.2%$5.9M+47.6%$5.7M+64.9%$5.4M+84.1%$4.7M+92.0%$4.0M+100.2%$3.5M+127.1%$2.9M+1248.1%
Non-Current Liabilities$56.9M-45.8%$56.0M-45.5%$58.9M-42.1%$106.6M-46.5%$105.0M-46.7%$102.8M-47.0%$101.8M-46.9%$199.1M-25.2%
Total Equity-$24.4M-9.4%-$23.5M-12.7%-$26.3M-30.0%-$23.4M-21.6%-$22.3M-15.1%-$20.8M-11.2%-$20.3M-9.3%-$19.3M-9.0%
Retained Earnings-$24.4M-9.4%-$23.5M-12.7%-$26.3M-30.0%-$23.4M-21.6%-$22.3M-15.1%-$20.8M-11.2%-$20.3M-9.3%-$19.3M-9.0%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

RENEF Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RENEF quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow-$206K-103.0%-$58K+63.0%-$331K+28.5%-$186K-110.1%-$102K-22.9%-$155K+13.7%-$463K+2.7%-$88K+53.7%
Investing Cash FlowN/AN/A$51.0M-48.6%-$750K-66.7%-$650K-44.4%-$450K0.0%$99.2M-$450K
Financing Cash FlowN/AN/A-$50.5M+48.8%$750K+7.1%$900K+100.0%$450K-35.7%-$98.7M-28.7%$700K

Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

RENEF Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

RENEF quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Return on Assets-1.8%-1.6pp8.1%+7.4ppN/A0.4%-1.2pp-0.2%-1.3pp0.7%-0.8ppN/A1.6%+0.8pp
Current Ratio0.040.0x0.040.0x0.06-0.1x0.02-0.1x0.080.0x0.07-0.1x0.13-0.1x0.09-0.3x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Debt-to-Equity, Asset Turnover, FCF Margin.

Note: Shareholder equity is negative (-$26.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.06), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

Is CARTESIAN GRTH CP II CL A profitable?

No, CARTESIAN GRTH CP II CL A (RENEF) reported a net income of -$1.5M in fiscal year 2025.

What is CARTESIAN GRTH CP II CL A's operating cash flow?

CARTESIAN GRTH CP II CL A (RENEF) recorded an outflow of $774K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are CARTESIAN GRTH CP II CL A's total assets?

CARTESIAN GRTH CP II CL A (RENEF) had $38.3M in total assets as of fiscal year 2025, including both current and long-term assets.

Yes, CARTESIAN GRTH CP II CL A (RENEF) spent $51.2M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

CARTESIAN GRTH CP II CL A (RENEF) had a current ratio of 0.06 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

CARTESIAN GRTH CP II CL A (RENEF) had a return on assets of -4.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

CARTESIAN GRTH CP II CL A (RENEF) has negative shareholder equity of -$26.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

CARTESIAN GRTH CP II CL A (RENEF) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

CARTESIAN GRTH CP II CL A (RENEF) reported a net loss of $1.5M while operations used $774K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top